XML 22 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (24,830,691) $ (20,144,478)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 163,431 173,185
Issuance of common stock and options for services 437,729 534,425
Modification of warrants issued to consultants 0 76,991
Equity based compensation 4,570,999 1,493,134
Common stock contributed to 401(k) plan 123,066 115,970
Impairment loss on abandonment of patents 0 240
Loss on retired equipment 313 0
(Gain) or loss on derivative instruments (1,808,954) 1,053,755
Loss on debt extinguishment 641,276 0
(Increase)/decrease in assets:    
Receivables (76,672) (6,177)
Deferred rent 559,828 571,125
Prepaid expenses (283,864) (73,752)
Inventory used for R&D and manufacturing 36,513 (397,076)
Deposits 150,000 (200,000)
Increase/(decrease) in liabilities:    
Accounts payable 1,856,635 (571,756)
Accrued expenses (117,207) 256,199
Deferred revenue (1,591) 46
Due to employees 95,214 (76,235)
Deferred rent liability (5,795) (2,245)
Net cash used in operating activities (18,489,770) (17,196,649)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of equipment (56,616) (66,912)
Expenditures for patent costs (9,422) (33,262)
Net cash used in investing activities (66,038) (100,174)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock and warrants 21,278,905 28,428,641
Proceeds from exercise of warrants 0 3,118,387
Payments on obligations under capital lease (6,290) (6,104)
Net cash provided by financing activities 21,272,615 31,540,924
NET INCREASE IN CASH AND CASH EQUIVALENTS 2,716,807 14,244,101
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 8,513,620 41,612
CASH AND CASH EQUIVALENTS, END OF PERIOD 11,230,427 14,285,713
ACCOUNTS PAYABLE    
Increase in research and office equipment 12,625 20,605
Decrease in capital lease obligation 32 3,466
(Decrease) increase in patent costs (975) 6,099
Increase in direct financing costs 128,630 0
(Increase) in accounts payable (140,312) (30,170)
Total 0 0
ADDITIONAL PAID IN CAPITAL    
(Increase) in derivative liabilities (8,463,957) (5,320,989)
Decrease (Increase) in common stock 1,000 (16,375)
Increase in prepaid services 20,464 6,612
Increase in patent costs 0 9,999
Decrease in additional paid in capital 8,442,493 5,320,753
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Cash paid for interest expense $ 124,914 $ 139,313